文献速递糖尿病

动脉粥样硬化多种族研究和鹿特丹研究中新发2型糖尿病的血清代谢组学分析

Serum Metabolomic Profiling of Incident Type 2 Diabetes Mellitus in the Multi-ethnic Study of Atherosclerosis and Rotterdam Study.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

研究在MESA(n=3460)和鹿特丹研究(n=1556)中采用1H NMR代谢组学分析血清代谢物与新发2型糖尿病的关联,发现19种代谢物显著相关,涉及氨酰-tRNA生物合成、支链氨基酸代谢、糖酵解/糖异生和甘油酯代谢;将重复验证的代谢物加入Framingham糖尿病风险评分后预测性能有轻至中度改善,MESA的ΔC统计量为0.05(95%CI 0.04-0.07),鹿特丹研究为0.03(95%CI 0.01-0.05)。

要点

  • 19种血清代谢物与新发2型糖尿病显著相关。
  • 涉及氨酰-tRNA生物合成、支链氨基酸代谢、糖酵解/糖异生和甘油酯代谢。
  • 加入代谢物后预测性能轻至中度改善,MESA的ΔC统计量0.05,鹿特丹研究0.03。

核心结论

  • 1H NMR测定的参与氨酰-tRNA生物合成、支链氨基酸代谢、糖酵解/糖异生和甘油酯代谢的代谢物与新发2型糖尿病显著相关,并在传统危险因素之外提供轻至中度的预测效用。

研究设计与样本

  • 在动脉粥样硬化多种族研究(MESA;n=3460;发现队列)和鹿特丹研究(RS;n=1556;重复验证队列)中开展基于非靶向质子核磁共振(1H NMR)光谱的代谢组学分析。
  • 采用多变量病因特异性风险模型分析23571种血清代谢组学光谱变量与新发2型糖尿病的关联。
  • 重复验证的代谢物需在MESA中错误发现率校正P<.01、在RS中P<.05且关联方向一致。
  • 进行通路和网络分析以阐明2型糖尿病发展的生物学机制。
  • 基于Framingham糖尿病风险评分评估重复验证代谢物改善2型糖尿病风险预测的效用。

主要发现

  • 19种代谢物与新发2型糖尿病显著相关。
  • 通路分析揭示氨酰-tRNA生物合成、支链氨基酸(BCAA)代谢、糖酵解/糖异生和甘油酯代谢紊乱。
  • 网络分析识别出与上游调节因子的相互作用,包括p38丝裂原活化蛋白激酶、c-Jun N端激酶和哺乳动物雷帕霉素靶蛋白信号通路。
  • 将重复验证的代谢物加入Framingham糖尿病风险评分后,在MESA和RS中预测性能显示轻至中度改善,MESA的ΔC统计量为0.05(95%CI 0.04-0.07),RS为0.03(95%CI 0.01-0.05)。
  • 遗传性增加的BCAA和甘露糖与2型糖尿病相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to investigate serum metabolomic biomarkers associated with incident type 2 diabetes mellitus (T2DM) and evaluate their performance in improving T2DM risk prediction. METHODS: Untargeted proton nuclear magnetic resonance (1H NMR) spectroscopy-based metabolomics analyses were conducted in the Multi-Ethnic Study of Atherosclerosis (MESA; n = 3460; discovery cohort) and The Rotterdam Study (RS; n = 1556; replication cohort). Multivariable cause-specific hazards models were used to analyze the associations between 23 571 serum metabolomic spectral variables and incident T2DM. Replicated metabolites required an false discovery rate-adjusted P < .01 in MESA, P < .05 in RS, and consistent direction of association. Pathway and network analyses were conducted to elucidate biological mechanisms underlying T2DM development. The utility of the replicated metabolites in improving T2DM risk prediction was assessed based on the Framingham Diabetes Risk Score. A 2-sample Mendelian randomization was conducted to assess causal associations. RESULTS: Nineteen metabolites were significantly associated with incident T2DM. Pathway analyses revealed disturbances in aminoacyl-tRNA biosynthesis, metabolism of branched-chain amino acids (BCAAs), glycolysis/gluconeogenesis, and glycerolipid metabolism. Network analyses identified interactions with upstream regulators including p38 mitogen-activated protein kinases, c-Jun N-terminal kinase, and mammalian target of rapamycin signaling pathways. Adding replicated metabolites to the Framingham Diabetes Risk Score showed modest to moderate improvements in prediction performance in MESA and RS, with Δ C-statistic of 0.05 [95% confidence interval (CI), 0.04-0.07] in MESA and 0.03 (95% CI, 0.01-0.05) in RS. Genetically increased BCAAs and mannose were associated with T2DM. CONCLUSION: 1H NMR measured metabolites involved in aminoacyl-tRNA biosynthesis, BCAA metabolism, glycolysis/gluconeogenesis, and glycerolipid metabolism were significantly associated with incident T2DM and provided modest to moderate predictive utility beyond traditional risk factors.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Jiang X, Zhu F, Graça G, et al. Serum Metabolomic Profiling of Incident Type 2 Diabetes Mellitus in the Multi-ethnic Study of Atherosclerosis and Rotterdam Study. J Clin Endocrinol Metab. 2025. PMID: 39566105. doi:10.1210/clinem/dgae812

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。